LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML
LSD1抑制剂通过重新激活急性髓系白血病（AML）中的PU.1和C/EBPα依赖性增强子发挥其抗白血病作用。
期刊:Blood
影响因子:23.1
doi:10.1182/blood-2017-09-807024
Cusan, Monica; Cai, Sheng F; Mohammad, Helai P; Krivtsov, Andrei; Chramiec, Alan; Loizou, Evangelia; Witkin, Matthew D; Smitheman, Kimberly N; Tenen, Daniel G; Ye, Min; Will, Britta; Steidl, Ulrich; Kruger, Ryan G; Levine, Ross L; Rienhoff, Hugh Y Jr; Koche, Richard P; Armstrong, Scott A
